Handbook of Clinical medicine

• Blood tests: FBC, U&E, LFT, CRP, ESR, electrophoresis, LDH, CK, ANA, ANCA, rheumatoid fac- tor, HIV test, malaria smear, interferon-gamma release assay for TB (p394). • Microscopy and culture: Blood ≈3, urine, sputum (including AFB), stool, CSF. • Imaging: CXR, abdominal/pelvic USS, venous Doppler. Consider: CT(PA), MRI, echo (TOE). Fluorodeoxyglucose-PET (FDG-PET) highlights areas of glucose uptake including tu- mour and infl ammation. It may aid/direct diagnosis in up to 50% of PUO. • Other: Hepatitis serology, CMV, EBV, autoimmune screen, cryoglobulins, toxoplasmo- sis, brucellosis, Coxiella, lymph node biopsy, endoscopy, temporal artery biopsy. Table 9.30 PUO diff erential according to history and examination fi ndings History Diff erential Animal contact Brucellosis, toxoplasmosis, Bartonella, leptospirosis, Q fever, psittacosis Cough TB, PE, Q fever, enteric fever, sarcoidosis, legionnaire’s disease Nasal symptoms Sinusitis, GPA, relapsing fever, psittacosis Confusion TB, Cryptococcus, sarcoid, carcinomatosis, brucellosis, enteric fever Arthralgia SLE, infective endocarditis, Lyme disease, brucellosis, TB, IBD Weight loss Malignancy, vasculitis, TB, HIV, IBD, thyrotoxicosis Family history Familial Mediterranean fever Drug history Drug-induced fever (~7–10d after new drug) Examination Diff erential Conjunctivitis Leptospirosis, relapsing fever, spotted fever, trichinosis Uveitis TB, sarcoid, adult Still’s disease, SLE, Behçet’s disease Mouth Dental abscess, Behçet’s disease, CMV, IBD Lymphadenopathy Lymphoma,
